<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-clonazepam.xml</id>
  <title>Recalls Watch: Clonazepam</title>
  <link rel="self" href="https://recalls.watch/feed/substance-clonazepam.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2025-01-15T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/95778/</id>
    <title>Endo USA, Inc.: Clonazepam Orally Disintegrating Tablet and 3 more</title>
    <link href="https://recalls.watch/recall/fda/95778/"/>
    <updated>2025-01-15T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-endo-expands-voluntary-recall-clonazepam-orally-disintegrating-tablets-usp-c-iv-/</id>
    <title>Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling</title>
    <link href="https://recalls.watch/recall/fda/n-endo-expands-voluntary-recall-clonazepam-orally-disintegrating-tablets-usp-c-iv-/"/>
    <updated>2024-11-21T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Mislabeled with the incorrect strength on the carton</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94945/</id>
    <title>Endo Pharmaceuticals, Inc.: Clonazepam Orally Disintegrating Tablets</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94945"/>
    <updated>2024-08-07T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-endo-usa-inc-issues-voluntary-nationwide-recall-one-lot-clonazepam-orally-disint/</id>
    <title>Endo USA, Inc: Par Pharmaceutical: Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.25 mg tablets</title>
    <link href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/endo-usa-inc-issues-voluntary-nationwide-recall-one-lot-clonazepam-orally-disintegrating-tablets-usp"/>
    <updated>2024-07-17T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Mislabeled with the incorrect strength on the carton</summary>
  </entry>
</feed>
